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Abstract
A full-length human creatine kinase B (B-CK) cDNA was used to produce a recombinant baculovirus (AcDZl-BCK). Sf9 cells 
infected with this recombinant expressed a homodimeric protein composed of 43 kDa subunits which, under optimal condi­
tions, formed up to 30% of the total soluble cellular protein. Upon analysis by PAGE, zymogram assay and gel filtration chro­
matography the recombinant protein behaved like authentic dimeric human BB-CK protein. Studies with a newly produced 
monoclonal antibody (CK-BYK/21E10) directed against an epitope in the N-terminus of the protein confirmed the identity of 
the product. The recombinant BB-CK protein was purified to over 99% homogeneity from the total protein extract of AcDZl- 
CKB infected cells in one single step involving anion exchange column chromatography on MonoQ in FPLC. Dialysed pro­
tein had a specific activity of 239 U/mg protein. (Mol Cell Biochem 143: 59-65, 1995)
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Introduction
Different isoforms of creatine kinase (CKs1; EC 2.7.3.2) play 
an important role in the energy metabolism of vertebrate 
cells by catalyzing the reversible exchange of high-energetic 
phosphate between ATP and creatine phosphate (CrP) [1]. 
CKs, the homo- or heterodimeric cytosolic BB, BM and MM 
enzymes [2] or the dimeric and octameric mitochondrial 
proteins [3], are indeed most prominently expressed in cells 
and tissues with a high and fluctuating energy demand such 
as cells in the central nervous system (CNS), cardiac and 
skeletal muscle, kidney, retina and spermatozoa [2 and refs, 
therein]. Consequently, expression of the different enzymatic 
subforms is subject to complex tissue and cell-type specific 
regulation. The B-CK subunit forms an especially interest­
ing study object in this respect. Not only are transcriptional 
and translational principles involved in its expression, also
the modulation of enzymatic activity by protein modifica­
tion [phosphorylation; 4] and non-covalent protein and 
membrane associations [5, 6] do play a role. B-CK studies 
may therefore form a paradigm for the study of other CK- 
isoforms or enzymes with a similar role in the ATP regula­
tory networks. The BB-CK isoenzyme has also a direct link 
to clinical applications. The determination of BB-CK in 
circulation is of importance in the investigation of neuro­
muscular (genetic) disorders, the monitoring of different 
events in the process of cardiac infarction, strokes, CNS and 
muscular traumas and the development of malignancies [7— 
11]. Development of reliable standardized tests for B-CK 
activity in human serum thus far has been hampered by the 
limited availability of pure enzyme as a control standard for 
enzyme activity determinations and by the lack of antibod­
ies specific against B-CK.
The baculovirus expression vector system developed by
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Smith et al. (1983) has been used for high level expression 
of eukaryotic proteins, including multimeric proteins and 
proteins which undergo post-translational modifications [13, 
14]. Here we present the use of the baculovirus expression 
vector system for the production of large quantities of 
authentic, enzymatically active, human BB-CK dimeric pro­
tein. Furthermore, we report on the production of a mono­
clonal antibody (CK-BYK/21E10) highly specific against 
the N-terminal portion of B-CK. which was used to estab­
lish the identity of the in vitro produced protein. The avail­
ability of pure subunits and a highly specific monoclonal 
antibody opens up future possibilities for the study of the 
pleiotropy of associations and modifications involved in the 
subcellular compartmentalization of B-CK. Moreover, it 
forms a valuable asset in the development of standardized 
immuno-assay kits for clinical chemical monitoring.
Material and methods
Viruses and cells
BamHI cleaved pAcDZl vector standard cloning methods 
were used [18], The orientation and integrity of the reading 
frame was checked by supercoil DNA sequencing [16] us­
ing B-CK specific primers.
Generation o f  recombinant A cM N PV
One \ig of purified pAcDZl-BCK transfer vector DNA was 
cotransfected with 2 (j.g pure wt AcMNPV DNA into Sf9 
cells (80-85% confluency) using lipofectin transformation 
(GIBCO-BRL) according to the manufacturers protocol [see 
also Peng et a l , 20]. Transfected cells were assayed for the 
production of recombinant AcMNPV-BCK virus using rou­
tine (3-galactosidase staining procedures. Recombinant vi­
rus was further isolated from culture supernatant through 
four rounds of plaque purification. A soft agar overlay was 
added to assist in picking of pure clones. Recombinant 
plaques were scored as lacking polyhedra and positive for 
P-galactosidase [21]. One purified plaque was chosen and 
expanded to a large seeding stock of recombinant virus 
(stored at 4°C).
Sf9 cells, derived from the armyworm S podop tera  f r u g i- 
p erd a , were grown at 27°C in flasks using Grace’s Insect 
medium (Gibco) [14] supplemented with 3.3 g/I yeastolate, 
3.3 g/1 lactalbumin hydrolysate (Gibco), 5.6 g/1 BSA and 
10% fetal bovine serum. The wild-type strain E2 of Auto- 
grapha ca lifo rn ica  multiple-nucleocapsid nuclear poly- 
hedrosis virus (AcMNPV) was used The wild-type and 
recombinant viruses were propagated and titrated (plaque 
assay, p.fu. determination) on loosely adherent monolayers 
of Sf9 cells as described [15]*
Construction o f  the recom binant expression vector
One forward primer (5 '-CTTGGATCCATGCCCTTCTCC- 
AACAGCCAC-3') and one reverse primer (5 '-CTTGGA- 
TCCGGCTTCArTTCTGGGCAGGCA-3') were designed 
for PCR amplification of the 1148 bp DNA fragment span­
ning the complete B-CK open reading frame (start and stop 
codon underlined). GGATCC sequences (bold print) were 
included in the primers to bracket the segment between 
flanking BamHI restriction sites. For PCR amplification, 
alkaline denatured [16] plasmid pCKB-131 DNA [17] served 
as template and standard conditions were used for genera­
tion and isolation of the DNA product [18]. Next, the 1158 
bp BamHI fragment (including primer sequences) was 
cloned downstream of the polyhedrin promoter in the 
baculovirus transfer vector pAcDZl which contains an E. 
coli LacZ marker for facilitating recombinant'■virus identi­
fication [19]. To introduce the B-CK DNA insert into the
Production and purification o f  B -C K  protein  from  
baculovirus infected S/9 cells
For optimization of production of B-CK protein, Sf9 cells 
were infected at different multiplicities of infection (moi’s 
ing from 1—10). To this end, Sf9 cells were seeded in 
25 cm2-flask in 4 ml medium at a density of 1.106 cells/ml 
and were infected with recombinant virus at the appropri­
ate dilution for 1 h. For harvest, the cells were collected by 
brief centrifugation at the appropriate time interval after 
infection (48—72 h), washed in cold phosphate-buffered sa­
line (PBS, 7.3 mM NaH2P04; 55 mM KC1, 47 mM NaCl, 
6.8 mM CaCl2, pH6.2), resuspended in 8 ml of 0.05 M Tris- 
HC1 (pH = 7.5), 5 mM 2-mercaptoethanol in the presence 
of 50 jag/ml PMSF and lysed by 3 cycles of freeze-thawing 
at—80°C.The lysate was centrifuged at 4,000 xg for 10 min 
and either used directly or stored frozen until use. Recom­
binant B-CK protein production was verified by SDS-PAGE 
[22] and standard CK-activity assays. The total protein con­
centration in the lysate or in purified fractions was meas­
ured using the method of Bradford et a l  [23],
For preparative purification, cell lysates were adjusted to 
10 mM MgCl2 and subjected to a 1-h treatment with 10 jig/ 
ml DNAsel followed by an additional centrifugation at 
12,000 rpm to remove protein aggregates, cell debris and 
unbroken cell organelles. Approximately 3.5 ml of the lysate 
(7.6 mg of protein) was then applied on a MonoQ FPLC- 
column and protein was eluted using a 0-0.8 M NaCl 
gradient in the above Tris/HCl-buffer. B-CK activity in in­
dividual fractions was determined and individual fractions 
were resolved by SDS-PAGE. The fractions highest in 43 kDa 
B -C K  protein were pooled, dialysed against phosphate-buff­
ered saline (PBS), and protein concentrations determined.
Production o f  a p ep tid e  immunogen and o f  a monoclonal 
antibody against human B -C K
The peptide immunogen BW-17 (Ser-Asn-Ser-His-Asn-Ala- 
Leu-Lys-Leu-Arg-Phe-Pro-Ala-Glu-Asp-Glu-Phe) corre­
sponding to a unique stretch of amino acids (residues 4—20) 
from the N-terminal end of the human B-CK was produced 
by standard solid phase synthesis [24], The purity of the 
peptide was assessed by determination of its amino acid com­
position and by routine HPLC analysis. Next, activated BW- 
17 peptide was coupled to BSA using MHS as described (25), 
yielding a ratio of 16 moles of peptide per mole of BSA.
For immunisation of Balb/C mice, 80 t^g of the BW-17- 
BSA conjugate in 300 jal PBS was mixed in with 300 i^l 
Freunds adjuvant and injected intraperitoneally at day one. 
Preimmune serum was taken prior to immunisation. Booster 
injections of 80 jag immunogen in incomplete Freunds 
adjuvant were given at days 14 and 28. Fusion experiments 
for hybrydoma production were started at around day 33. 
The standard methodology for fusion of immunized Balb/ 
C spleen cells with SP2/0AG14 myeloma cells was used 
[26]. Hybridomas were screened by standard ELISA on
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plates coated with (i) recombinant B-CK/|3-galactosidase 
fusion protein produced in E. c o l i , (ii) synthetic BW-17 
peptide conjugated to casein or thyroglobulin, (iii) Sf-9 
lysate from wt or recombinant AcMNPV-BCK or (iv) 
commercially available M-CK protein (Boehringer) as a 
negative control. Promising clones were recloned twice by 
limiting dilution and their specificity was further verified 
on Western blots as described below. Ultimately, monoclonal 
(MoAb) CK-BYK/21E10 was chosen for its high specificity 
and stable growth characteristics. Nude Balb/C mice were used 
to produce ascites fluid. MoAb CK-BYK/21E10 is an lgG2b.
Typing o fp u r if ied  recombinant B -C K  protein: SDS-PAGE  
analysis
Protein was resolved by SDS-PAGE in 10% (w/v) slab gels 
and then, for Western blotting, electrophoretically trans­
ferred to a nitrocellulose membrane (Schleicher and Schull) 
(1 h; 250 mA) in a buffer containing 25 mM Tris-HCl (pH 
= 8.3), 192 mM glycine, and 20% (v/v) methanol. Alterna­
tively, for routine analysis the gels were directly stained with 
Coomassie Brilliant Blue or silver stain [27] to verify the 
purity of the B-CK preparation. For immunoblot analyses, 
nitrocellulose sheets were first blocked with 1% gelatin in
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Tris-buffered saline/Tween 20(10 mM Tris-HCl pH 8.0,150 
mM NaCl, 0,05% Tween 20; TBST) followed by incubation 
with MoAb antibody CK-BYK/21 E l0 at the appropriate 
dilution (1:50.000 for ascites MoAb). Filters were washed 
extensively in TBST and then incubated with a secondary 
antibody consisting of alkaline phosphatase-conjugated goat 
anti-mouse IgG (Promega Biotec). The color was developed 
with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl 
phosphate substrate using the Protoblot AP system accord­
ing to the specifications of the manufacturer (Promega).
Protein sizing by g e l f iltra tio n
Protein in the dialyzed pure pooled peak fractions of the 
Mono-Q column (950 |ig/ml; 2.5 ml total) was brought on 
a FPLC-Superdex 200 column (gelfiltration column of 
Pharmacia/LKB FPLC system) to see whether B-CK was 
present in its monomeric or dimeric form. Retention in the 
elution was calibrated with a series of known proteins such 
as aldolase, bovine serum albumin and ovalbumin. The 
various fractions of the Superdex 200 elution protein were 
tested in standard CK-activity assays for the specific activ­
ity of the protein (in standard CK Units per mg protein/1). 
Finally, the immunogenicity of B-CK in the pooled fraction 
of the MonoQ column was retested by Western blotting.
D eterm ination o f  C K -activity
Accurate determination of CK-activity was performed using 
the CK-NAC activated method (CBR-program Boehringer 
Mannheim; CBR-CKNAc-activatedkitno. 475742) adapted 
for a Cobas Myra automatic analyser (Hoffman La Roche, 
Basel, Switzerland).
Zym ogram typing o f  C K  isoenzym es
Typing of cytosolic CK isoenzymes in cell lysates was done 
by applying the lysate to cellulose acetate membrane strips 
(Sartorius) prior to electrophoretic separation at 200 V for
1 h in Tris-barbital buffer pH 8.6 as described by Harm e t  
ah [28]. The positions of CK activity were vizualized by 
activity staining according to Kanemitsu e t  ah [29].
Results and discussion
Recombinant baculovirus expressing the B-CK protein was 
isolated as described under ‘Materials and methods’. To 
determine whether insect Sf9 cells infected with this plaque-
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tibody (CK-B YK/21E10). The antibody does not detect any 
significant quantity of protein in uninfected cells and the re­
combinant protein has a size that exactly corresponds to that 
of native B-CK subunits from human brain or heart extracts.
The B-CK expressed in insect cells was purified to ho­
mogeneity in one single step by applying the total cell lysate 
on a monoQ FPLC-column and eluting the column with a 
0-0.8 M NaCl gradient. Monitoring of individual fractions 
showed that virtually pure B-CK eluted as one peak at 0.27 
M NaCl (Fig. 2A). The creatine kinase activity in the pooled 
fractions, after dialysis against phosphate-buffered saline, 
was determined to be 239 U/mg protein, an enrichment of 
2.5 fold as compared to the CK activity determined in the 
total cell lysate before column chromatography (98 U/mg 
protein). Silver and Coommassie staining showed that B-CK 
in the fractions with highest activity was essentially pure and 
comprised over 99% of the total visible protein bands Fig. 
2B, left panel). This was confirmed by Western blot analy­
sis with MoAb CK-B YK/21E1Q (Fig. 2B, right panel), which 
also demonstrates that through this purification step the 
weak ± 40 kDa proteolytic fragment present in the crude 
lysate was lost. When the pooled protein eluted from the 
MonoQ column was brought on a FPLC-Superdex-200 col­
umn (gelfiltration column), the protein (and the activity 
profile) behaved like a 80-90 kDa protein indicating that B- 
CK was present in its native dimeric form (Fig. 2C). B-CK 
in brain extracts was used as a control and eluted at exactly 
the same position (not shown). Zymogram typing (Fig. 2D) 
showed that the purified recombinant protein migrated ex­
actly as native BB-CK from human cells.
Taken together, these results indicate that most if not all 
of the recombinant BB-CK produced in insect cells behaves 
like authentic native, enzymatically functional BB-CK pro­
tein. The product is similar to dimeric BB-CK protein as 
found in human tissues. High levels of BB-CK are for ex­
ample found in the CNS, the epithelial linings of lung and 
intestine, photoreceptor cells of the retina, the thick ascend­
ing limb of the loop of Henle in kidney, osteoclasts, and 
uterus during labour [2 and refs, therein]. Several reports 
emphasize the role of BB-CK in regenerating ATP for so­
dium transport and its has been suggested that BB-CK is 
closely associated to Na,K-ATPases in these tissues [32]. The 
availability of biologically active preparations of purified 
native CK-B subunits will make possible reconstitution stud­
ies to determine the nature of these associations. Fortunately, 
the expression and correct assembly of functional Na,K- 
AFPase subunits in baculovirus-infected insect cells has also 
been reported [33]. Ultimately, these studies may provide 
us with more insight in B-CK’s biological properties and the 
role of protein-structural flexibility in partitioning and 
intracellular compartmentalization phenomena. In addition, 
the baculovirus expression vector system is an attractive 
venue for producing large amounts of pure native B-CK
protein which can be used as standard in serological tests 
for brain and cardiac infarction [8, 9], Until now, transient 
production of CK proteins in cDNA transfected COS cells 
[34] was the method of choice for production of CKs for 
potential use as clinical standards. Also the newly generated 
monoclonal antibody CK-BYK/21E10 can be considered a 
useful tool in these tests.
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